{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:27:46Z","timestamp":1787016466621,"version":"build-2736575974"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Current combination therapies cure\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    infection in 75 to 85% of cases. However, many treatment failures are not explained by antibiotic resistance. Our goal was to explore treatment failures under in vivo conditions by using the\n                    <jats:italic>H. pylori<\/jats:italic>\n                    Sydney strain (SS1) mouse model. Mice infected with\n                    <jats:italic>H. pylori<\/jats:italic>\n                    (SS1) were treated with monotherapies or combination therapies used in human trials. Bacterial levels and distribution of organisms within the stomach were assessed 24 h after treatment to determine clearance and location of treatment failures and 29 days after treatment to determine cure rates. Except for treatment with metronidazole, mono- and dual therapies did not cure infection but resulted in decreases in bacterial levels and differences in distribution within the stomach. In cases of treatment failure when clarithromycin was used, omeprazole and dual therapy with omeprazole and amoxicillin resulted in organisms being cleared from the antrum, but organisms remained in the antrum-body transitional zone. The triple therapies of OMC and bismuth subcitrate, metronidazole, and tetracycline were successful in eradicating infection. Except for metronidazole monotherapy and triple therapy with OAC, there was good correlation between the Sydney strain mouse model and humans with respect to the success of antimicrobial therapy. The antrum-body transitional zone was identified as a sanctuary site in treatment failure. This could result from antimicrobial agents not functioning effectively at this site or bacteria in this location expressing products that protect them against antimicrobial agents. This is the first demonstration of a possible sanctuary site as a reason for failure of therapy.\n                  <\/jats:p>","DOI":"10.1128\/aac.47.7.2249-2255.2003","type":"journal-article","created":{"date-parts":[[2003,6,23]],"date-time":"2003-06-23T15:17:06Z","timestamp":1056381426000},"page":"2249-2255","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Gastric Transitional Zones, Areas where\n                    <i>Helicobacter<\/i>\n                    Treatment Fails: Results of a Treatment Trial Using the Sydney Strain Mouse Model"],"prefix":"10.1128","volume":"47","author":[{"given":"Sander J. O. Veldhuyzen","family":"van Zanten","sequence":"first","affiliation":[{"name":"Queen Elizabeth II Health Sciences Center, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassia","family":"Kolesnikow","sequence":"additional","affiliation":[{"name":"University of New South Wales, School of Biotechnology and Biomolecular Sciences, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine &amp; Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani L.","family":"O'Rourke","sequence":"additional","affiliation":[{"name":"University of New South Wales, School of Biotechnology and Biomolecular Sciences, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Lee","sequence":"additional","affiliation":[{"name":"University of New South Wales, School of Biotechnology and Biomolecular Sciences, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2000.01918.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0924-8579(00)00133-3","volume":"14","year":"2000","unstructured":"Andersen, L. P., H. Colding, and J. E. Kristiansen. 2000. Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate. Int. J. Antimicrob. Agents14:231-234.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0035-9203(99)90089-5","volume":"93","year":"1999","unstructured":"Ani, A. E., A. O. Malu, J. A. Onah, D. M. M. Queiroz, G. Kirschner, and G. A. Rocha. 1999. Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria. Trans. R. Soc. Trop. Med. Hyg.93:659-661.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_5_2","first-page":"203","volume":"12","year":"2001","unstructured":"Asghar, R. J., and J. Parsonnet. 2001. Helicobacter pylori and risk for gastric adenocarcinoma. Semin. Gastrointest. Dis.12:203-208.","journal-title":"Semin. Gastrointest. Dis."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/gut.36.5.670","volume":"36","year":"1995","unstructured":"Atherton, J. C., A. Cockayne, M. Balsitis, G. E. Kirk, C. J. Hawkey, and R. C. Spiller. 1995. Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine. Gut36:670-674.","journal-title":"Gut"},{"key":"e_1_3_2_7_2","first-page":"659","volume":"92","year":"1997","unstructured":"Bamba, H., Y. Kondo, R. M. Wong, S. Sekine, and F. Matsuzaki. 1997. Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method. Am. J. Gastroenterol.92:659-662.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.1995.tb00349.x","volume":"9","year":"1995","unstructured":"Bell, G. D., K. U. Powell, S. M. Burridge, A. F. Bowden, W. Atoyebi, G. H. Bolton, P. H. Jones, and C. Brown. 1995. Rapid eradication of Helicobacter pylori infection. Aliment. Pharmacol. Ther.9:41-46.","journal-title":"Aliment. Pharmacol. Ther."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90686-X"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529108996241"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/39.1.5","volume":"39","year":"1997","unstructured":"Erah, P. O., A. F. Goddard, D. A. Barrett, P. N. Shaw, and R. C. Spiller. 1997. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice\u2014relevance to the treatment of Helicobacter pylori infection. J. Antimicrob. Chemother.39:5-12.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91714-F"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00144743","volume":"4","year":"1988","unstructured":"Glupczynski, Y., M. Delmee, C. Bruck, M. Labbe, V. Avesani, and A. Burette. 1988. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. Eur. J. Epidemiol.4:154-157.","journal-title":"Eur. J. Epidemiol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/gast.1996.v111.pm8690200","volume":"111","year":"1996","unstructured":"Goddard, A. F., M. J. Jessa, D. A. Barrett, P. N. Shaw, J. P. Idstrom, C. Cederberg, and R. C. Spiller. 1996. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology111:358-367.","journal-title":"Gastroenterology"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963775"},{"key":"e_1_3_2_16_2","first-page":"183","volume":"30","year":"1998","unstructured":"Grove, D. I., G. Koutsouridis, and A. G. Cummins. 1998. Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. Pathology30:183-187.","journal-title":"Pathology"},{"key":"e_1_3_2_17_2","first-page":"292","volume":"82","year":"1987","unstructured":"Hazell, S. L., T. J. Borody, A. Gal, and A. Lee. 1987. Campylobacter pyloridis gastritis I: detection of urease as a marker of bacterial colonization and gastritis. Am. J. Gastroenterol.82:292-296.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_18_2","unstructured":"Hirschl A. M. and M. Pletschette. 1989. Antibiotic treatment of Campylobacter pylori infection p. 217-224. In B. J. Rathbone and R. V. Heatley (ed.) Campylobacter pylori and gastroduodenal disease. Blackwell Scientific Publications Ltd. Oxford England."},{"key":"e_1_3_2_19_2","first-page":"44","volume":"31","year":"1996","unstructured":"Hirschl, A. M., and M. L. Rotter. 1996. Amoxicillin for the treatment of Helicobacter pylori infection. J. Gastroenterol.31(Suppl. 9):44-47.","journal-title":"J. Gastroenterol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2623-2629.2000"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.777"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.11.4501-4507.1996"},{"key":"e_1_3_2_23_2","first-page":"395","volume":"4","year":"1997","unstructured":"Kuipers, E. J., J. G. Kusters, and W. A. Deboer. 1997. Current therapies of Helicobacter pylori infection. Bailliere's Clin. Infect. Dis.4:395-412.","journal-title":"Bailliere's Clin. Infect. Dis."},{"key":"e_1_3_2_24_2","first-page":"1401","volume":"90","year":"1995","unstructured":"Kuipers, E. J., A. M. Uyterlinde, A. S. Pena, H. Hazenberg, E. Bloemena, J. Lindeman, E. C. Klinkenbergknol, and S. Meuwissen. 1995. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am. J. Gastroenterol.90:1401-1406.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_25_2","first-page":"G33","volume":"254","year":"1988","unstructured":"Larsson, H., E. Carlsson, B. Ryberg, J. Fryklund, and B. Wallmark. 1988. Rat parietal cell function after prolonged inhibition of gastric acid secretion. Am. J. Physiol.254:G33-G39.","journal-title":"Am. J. Physiol."},{"key":"e_1_3_2_26_2","first-page":"461","volume":"7","year":"1995","unstructured":"Lee, A., M. F. Dixon, S. J. Danon, E. Kuipers, F. Megraud, H. Larsson, and B. Mellegard. 1995. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur. J. Gastroenterol. Hepatol.7:461-465.","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70155-0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70119-8"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.1.12"},{"key":"e_1_3_2_31_2","first-page":"167","volume":"16","year":"2002","unstructured":"Malfertheiner, P., F. Megraud, C. O'Morain, A. P. S. Hungin, R. Jones, A. Axon, D. Y. Graham, G. Tytgat, M. Asaka, F. Bazzoli, B. Birkner, J. Bures, A. Burette, P. Bytzer, L. Castro, A. Culhane, W. de Boer, J. De Korwin, E. De Koster, N. de Wit, M. Deltenre, J. Dent, F. Di Mario, B. Dragosics, M. Farkkila, et al. 2002. Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 consensus report. Aliment. Pharmacol. Ther.16:167-180.","journal-title":"Aliment. Pharmacol. Ther."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91816-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.t01-1-01079.x"},{"key":"e_1_3_2_34_2","first-page":"S49","volume":"7","year":"1995","unstructured":"Megraud, F. 1995. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol.7(Suppl. 1):S49-S54.","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jcp.51.3.220","volume":"51","year":"1998","unstructured":"Mirshahi, F., G. Fowler, A. Patel, and G. Shaw. 1998. Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity. J. Clin. Pathol.51:220-224.","journal-title":"J. Clin. Pathol."},{"key":"e_1_3_2_36_2","first-page":"1860","volume":"88","year":"1993","unstructured":"Peterson, W. L., D. Y. Graham, B. Marshall, M. J. Blaser, R. M. Genta, P. D. Klein, C. W. Stratton, J. Drnec, P. Prokocimer, and N. Siepman. 1993. Clarithromycin as monotherapy for eradication of Helicobacter pylori\u2014a randomized, double-blind trial. Am. J. Gastroenterol.88:1860-1864.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_37_2","first-page":"246","volume":"91","year":"1996","unstructured":"Treiber, G. 1996. The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. Am. J. Gastroenterol.91:246-257.","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0016-5085(97)80027-3","volume":"113","year":"1997","unstructured":"Unge, P. 1997. What other regimens are under investigation to treat Helicobacter pylori infection. Gastroenterology113(Suppl. 6S):S131-S148.","journal-title":"Gastroenterology"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70025-9"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/BF02088756","volume":"41","year":"1996","unstructured":"Veldhuyzen van Zanten, S. J. V., P. T., Pollak, H. Kapoor, and P. K. Yeung. 1996. Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori. Dig. Dis. Sci.41:1845-1852.","journal-title":"Dig. Dis. Sci."},{"key":"e_1_3_2_41_2","first-page":"177","volume":"150","year":"1994","unstructured":"Velduyzen van Zanten, S. J. O., and P. M. Sherman. 1994. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. Can. Med. Assoc. J.150:177-185.","journal-title":"Can. Med. Assoc. J."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018827322470"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.7.2249-2255.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.7.2249-2255.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T23:43:35Z","timestamp":1704843815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.7.2249-2255.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1128\/AAC.47.7.2249-2255.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.7.2249-2255.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"2002-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-04-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}